Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

1 min read
Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline
Image caption: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. Image credit: Reuters / Issei Kato. Article by Deena BeasleyJulie Steenhuysen and Rocky Swift. Reuters – updated September 28, 2022.

Sept 27 (Reuters) – An experimental Alzheimer’s drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs. […]

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.